Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Eli Lilly will start selling the two highest doses of its popular weight-loss drug Zepbound directly to customers online in ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

For those who prefer the convenience of getting Zepbound online, several verified options have passed our ... with the pens offering a wider range of doses and the vials requiring syringe ...

Lack of insurance coverage and high costs remain a barrier to obtaining tirzepatide. Eli Lilly’s weight loss drug Zepbound outperformed ... the maximum tolerated dose of one of the two ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...

Over the past several months, however, drugmakers Novo Nordisk and Eli Lilly have introduced lower-cost options ... which reduced Zepbound’s starter dose to $349 and higher doses to $499 ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients to adapt on the fly.

Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and ...

Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...

Poison-control centers are seeing a steady increase in calls related to weight-loss drugs, and the FDA shared a report detailing severe gastrointestinal issues people are experiencing when using ...